Table 1.
Relationship between APC11 overexpression and clinicopathologic characteristics in NSCLCs
| Variables | APC11 (−) |
APC11 (+) |
P-value |
|---|---|---|---|
| Sex | 0.443 | ||
| Female | 31 | 21 | |
| Male | 31 | 24 | |
| Age | 53+9.8 | 54.9+10.4 | 0.533 |
| Smoker | 0.086 | ||
| Former or current | 25 | 25 | |
| Never | 37 | 20 | |
| Tumor location | 0.744 | ||
| Right upper lobe | 25 | 13 | |
| Right middle lobe | 8 | 7 | |
| Right lower lobe | 12 | 12 | |
| Left upper lobe | 9 | 8 | |
| Left lower lobe | 8 | 5 | |
| Tumor size, mean±SD | 3.06+0.86 | 3.13+0.85 | 0.881 |
| Histology | 0.509 | ||
| Adenoca | 41 | 21 | |
| Seqcc | 21 | 16 | |
| Differentiation | 0.054 | ||
| Well | 22 | 22 | |
| Moderate | 21 | 18 | |
| Poor | 19 | 5 | |
| Pathologic stage | 0.640 | ||
| I | 23 | 13 | |
| II | 27 | 21 | |
| IIIA | 12 | 11 |